Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | 9.36 |
---|---|
High | 9.36 |
Low | 9.36 |
Bid | 8.69 |
Offer | 8.89 |
Previous close | 9.36 |
Average volume | -- |
---|---|
Shares outstanding | 54.43m |
Free float | 52.34m |
P/E (TTM) | -- |
Market cap | 61.51m USD |
EPS (TTM) | -0.526 USD |
Data delayed at least 15 minutes, as of Jun 09 2020.
More ▼
Announcements
- CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update
- CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference
- CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- CytoSorbents Reports Second Quarter 2024 Financial and Operational Results
- CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
- CytoSorbents to Report Second Quarter 2024 Operating and Financial Results
- CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement
- CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
- CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress
- CytoSorbents Secures $20 Million Credit Facility
More ▼